BlackRock Capital Allocation Term Trust (NYSE:BCAT) Hits New 1-Year High – What’s Next?

BlackRock Capital Allocation Term Trust (NYSE:BCAT)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $16.20 and last traded at $16.1650, with a volume of 150695 shares changing hands. The stock had previously closed at $16.08.

BlackRock Capital Allocation Term Trust Trading Down 0.4%

The business’s fifty day moving average is $15.78 and its 200 day moving average is $15.26.

BlackRock Capital Allocation Term Trust Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be issued a $0.2542 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 19.0%. The ex-dividend date is Tuesday, September 15th.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Geneos Wealth Management Inc. boosted its position in BlackRock Capital Allocation Term Trust by 341.7% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after acquiring an additional 1,582 shares during the last quarter. N.E.W. Advisory Services LLC lifted its position in shares of BlackRock Capital Allocation Term Trust by 100.0% in the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock worth $34,000 after purchasing an additional 1,200 shares in the last quarter. McIlrath & Eck LLC boosted its holdings in BlackRock Capital Allocation Term Trust by 169.6% during the first quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock worth $44,000 after purchasing an additional 1,969 shares during the last quarter. Parallel Advisors LLC acquired a new position in BlackRock Capital Allocation Term Trust during the third quarter worth $47,000. Finally, Brown Brothers Harriman & Co. grew its position in BlackRock Capital Allocation Term Trust by 450.0% in the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock valued at $81,000 after purchasing an additional 4,500 shares in the last quarter. 36.12% of the stock is currently owned by institutional investors.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.